
Quantum Cyber N.V.
QUCYNASDAQHealthcareMedical - Diagnostics & Research
Previous close
$1.30
−$0.06 · -4.41%
Pre-market
$1.27
−$0.03 · -2.31%
Aug 24, 7:53 AM ET
QUCY company overview
Regular session · ET · Market data may be delayed.
Company profile
Company websiteQuantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions. The company pursues acquisitions and partnerships in areas including post-quantum cryptography, zero-trust architecture, and national security technologies. It also develops platforms that integrate artificial intelligence (AI) and quantum computing technologies for autonomous control systems used in unmanned aerial, ground, and underwater vehicles, including drones, self-driving vehicles, and robotic fleets. Quantum Cyber N.V. was formerly known as Mainz Biomed N.V. and changed its name to Quantum Cyber N.V. in April 2026. The company is headquartered in Mainz, Germany.
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- Headquarters
- DE
- CEO
- David Elliot Lazar
- Listed since
- Nov 5, 2021
- Employees
- 13
Market position
Day range
Current $1.30
52-week range
Current $1.30
- Open
- $1.33
- Previous close
- $1.36
- Volume
- 1.05M
- 1.15× average
- Average volume
- 909.82K
- Average daily volume
- Market cap
- 29.6M USD
- Beta
- 2.32
- Market reference 1
- 50-day average
- $0.7385
- +76.03% above average
- 200-day average
- $0.7385
- +76.03% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 6.48M USD
- P/E (TTM)
- -3.02×
- P/B (TTM)
- 3.34×
- P/S (TTM)
- 103.23×
- EV / EBITDA
- -0.43×
- Earnings yield
- -337.90%
- Free cash flow yield
- -250.77%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 100.00%
- Operating margin
- -2723.55%
- Net margin
- -2937.85%
- Return on equity
- -2526.61%
- Return on assets
- -304.29%
- Return on invested capital
- -403.51%
Financial health
- Debt / equity
- 0.03×
- Current ratio
- 0.5×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 537.08K USD | 893.99K USD | 895.48K USD | 529.88K USD | 577.35K USD |
| Cost of goods sold | 147.29K USD | 319.11K USD | 385.82K USD | 347.73K USD | 399.73K USD |
| Gross profit | 389.79K USD | 574.88K USD | 509.66K USD | 182.15K USD | 177.62K USD |
| Research and development | 4.96M USD | 5.84M USD | 9.59M USD | 5.02M USD | 481.93K USD |
| Selling, general, and administrative | 8.88M USD | 12.77M USD | 17.22M USD | 21.45M USD | 9.38M USD |
| Operating expenses | 13.36M USD | 19.27M USD | 27.15M USD | 26.63M USD | 9.9M USD |
| Interest expense | 373.46K USD | 1.08M USD | 559.58K USD | 289.32K USD | 339.17K USD |
| Depreciation and amortization | 615.72K USD | 1.02M USD | 866.41K USD | 379.8K USD | 69.93K USD |
| Operating income | −12.97M USD | −18.7M USD | −26.64M USD | −26.44M USD | −9.72M USD |
| Net income | −16.21M USD | −21.65M USD | −26.3M USD | −26.39M USD | −11.69M USD |
Company facts updated Aug 24, 2026.
QUCY news
QUCY peers
Continue in GoAI
Research QUCYresearch.disclaimer











